Interactions of antiestrogens with human breast cancer in long-term tissue culture

Cancer Treatment Reports
|October 1, 1976
PubMed

Insights

Antiestrogens like tamoxifen inhibit growth in human breast cancer cells by blocking estrogen receptors. This effect is reversible with estrogen, but prolonged antiestrogen treatment leads to irreversible cell death.

Area of Science:

  • Endocrinology
  • Oncology
  • Cell Biology

Background:

  • Antiestrogens are used to treat metastatic breast cancer.
  • Their precise mechanism of action requires further elucidation.
  • Human breast cancer cell lines in long-term culture serve as a valuable model system.

Purpose of the Study:

  • To investigate the mechanism of action of various antiestrogens.
  • To determine the role of estrogen receptors in antiestrogen efficacy.
  • To examine the reversibility and irreversibility of antiestrogen effects on cancer cells.

Main Methods:

  • Utilized human breast cancer cell lines in long-term tissue culture.
  • Administered antiestrogens (tamoxifen, nafoxidine, CI-628, clomiphene citrate) and estradiol.
  • Assessed macromolecular synthesis inhibition and cell viability.
  • Performed competitive binding assays with radiolabeled estradiol and tamoxifen for estrogen receptors.

Main Results:

  • Antiestrogens inhibited macromolecular synthesis in estrogen receptor-positive cell lines.
  • Estradiol addition prevented or reversed antiestrogen-induced inhibition.
  • Prolonged antiestrogen exposure (over 3 days) resulted in irreversible cell death.
  • Tamoxifen competed with estradiol for estrogen receptors with lower affinity.

Conclusions:

  • Antiestrogen efficacy is dependent on the presence of estrogen receptors.
  • Estrogen can counteract antiestrogen effects, but prolonged exposure leads to irreversible damage.
  • Tamoxifen's binding affinity to estrogen receptors correlates with its cellular inhibitory effects.

Related Concept Videos